Hyperammonaemia

Gene: OTC

Green List (high evidence)

OTC (ornithine carbamoyltransferase)
EnsemblGeneIds (GRCh38): ENSG00000036473
EnsemblGeneIds (GRCh37): ENSG00000036473
OMIM: 300461, Gene2Phenotype
OTC is in 9 panels

3 reviews

Richard Scott (Genomics England Curator)

Comment on phenotypes: "Carbamoyl Phosphate Synthetase I Deficiency, Hyperammonaemia due to" removed as per Peter Clayton review 5/11/15
Created: 17 Dec 2015, 11:22 a.m.

Ellen McDonagh (Genomics England Curator)

Added the tag ‘gene-therapy-trial’ as this gene is within the Gene Therapy Panel available here: https://panelapp.genomicsengland.co.uk/panels/412
Created: 14 May 2018, 9:50 a.m.
Please note that phenotypes that already existed for this gene panel (viewed under Gene Summary) and Ensembl transcripts were accidently uploaded under Peter Clayton (UCL Institute of Child Health)'s review and were not suggested by him. We are working on a fix in PanelApp to correct this.
Created: 5 Nov 2015, 5:19 p.m.

Peter Clayton (UCL Institute of Child Health)

Green List (high evidence)

The phenotype should not include Carbamoyl Phosphate Synthetase I Deficiency, Hyperammonaemia due to Although clinical phenotype may be similar (hyperammonaemic encephalopathy) , laboratory results (e.g. urine orotic acid, enzymology) and mode of inheritance from family history are different
Created: 5 Nov 2015, 4:51 p.m.

Mode of inheritance
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)

Phenotypes
Ornithine Transcarbamylase Deficiency; Ornithine transcarbamylase deficiency, 311250

Details

Mode of Inheritance
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
Sources
  • Expert Review Green
  • Radboud University Medical Center, Nijmegen
  • UKGTN
  • Emory Genetics Laboratory
  • Illumina TruGenome Clinical Sequencing Services
Phenotypes
  • Ornithine transcarbamylase deficiency, 311250
Tags
gene-therapy-trial
OMIM
300461
Clinvar variants
Variants in OTC
Penetrance
Complete
Publications
Panels with this gene

History Filter Activity

22 Nov 2016, Gel status: 4

panel promoted to version 1

Sarah Leigh (Genomics England Curator)

Promoted to version 1 on 22nd November 2016

17 Aug 2016, Gel status: 4

Set Phenotypes

Sarah Leigh (Genomics England Curator)

Phenotypes for OTC were set to Ornithine transcarbamylase deficiency, 311250

17 Dec 2015, Gel status: 4

Set Phenotypes

Richard Scott (Genomics England Curator)

Phenotypes for OTC were set to Ornithine Transcarbamylase Deficiency; Ornithine transcarbamylase deficiency, 311250

17 Dec 2015, Gel status: 4

Set Phenotypes

Richard Scott (Genomics England Curator)

Phenotypes for OTC were set to Ornithine Transcarbamylase Deficiency; Ornithine transcarbamylase deficiency, 311250

17 Dec 2015, Gel status: 4

Gene classified by Genomics England curator

Richard Scott (Genomics England Curator)

This gene has been classified as Green List (High Evidence).

17 Dec 2015, Gel status: 4

Set publications

Richard Scott (Genomics England Curator)

Publications for OTC were set to 2983225

5 May 2015, Gel status: 4

Added New Source

Eik Haraldsdottir (Genomics England)

OTC was added to Hyperammonaemiapanel. Sources: Radboud University Medical Center, Nijmegen

5 May 2015, Gel status: 3

Added New Source

Eik Haraldsdottir (Genomics England)

OTC was added to Hyperammonaemiapanel. Sources: UKGTN

5 May 2015, Gel status: 2

Added New Source

Eik Haraldsdottir (Genomics England)

OTC was added to Hyperammonaemiapanel. Sources: Emory Genetics Laboratory

5 May 2015, Gel status: 1

Added New Source

Eik Haraldsdottir (Genomics England)

OTC was added to Hyperammonaemiapanel. Sources: Illumina TruGenome Clinical Sequencing Services